IL1B and chronic kidney disease: The results showed the levels of IL-1β, IL-6, and TNF-α in the peripheral serum of CKD mice after CLMD intervention were also significantly reduced, further confirming that CLMD intervention effectively improved the chronic inflammatory state of CKD mice.